[AHA]
Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)
Authors:Matthew M.Y. Lee; Katriona J.M. Brooksbank; Kirsty Wetherall; Kenneth Mangion; Giles Roditi; Ross T. Campbell; Colin Berry; Victor Chong; Liz Coyle; Kieran F. Docherty; John G. Dreisbach; Catherine Labinjoh; Ninian N. Lang; Vera Lennie; Alex McConnachie; Clare L. Murphy; Colin J. Petrie; John R. Petrie; Iain A. Speirits; Steven Sourbron; Paul Welsh; Rosemary Woodward; Aleksandra Radjenovic; Patrick B. Mark; John J.V. McMurray; Pardeep S. Jhund; Mark C. Petrie; Naveed Sattar